Compare, Analyse ALEMBIC PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
TEVA PHARMA
Dec-13
ALEMBIC PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6643,060-   
Low Rs4122,659-   
Sales per share (Unadj.) Rs208.71,756.4-  
Earnings per share (Unadj.) Rs31.0109.7-  
Cash flow per share (Unadj.) Rs37.1251.7-  
Dividends per share (Unadj.) Rs5.5096.05-  
Dividend yield (eoy) %1.03.4 30.4%  
Book value per share (Unadj.) Rs144.21,951.0-  
Shares outstanding (eoy) m188.52848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.61.6 158.4%   
Avg P/E ratio x17.426.1 66.6%  
P/CF ratio (eoy) x14.511.4 127.7%  
Price / Book Value ratio x3.71.5 254.6%  
Dividend payout %17.787.5 20.3%   
Avg Mkt Cap Rs m101,4612,424,839 4.2%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m7,4670-   
Avg. sales/employee Rs ThNM33,138.8-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,070.2-  
INCOME DATA
Net Sales Rs m39,3471,489,422 2.6%  
Other income Rs m940-   
Total revenues Rs m39,4411,489,422 2.6%   
Gross profit Rs m8,736407,879 2.1%  
Depreciation Rs m1,152120,391 1.0%   
Interest Rs m18429,255 0.6%   
Profit before tax Rs m7,493258,233 2.9%   
Minority Interest Rs m111,173 0.9%   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m0-169,516 0.0%   
Tax Rs m1,568-3,153 -49.7%   
Profit after tax Rs m5,84493,043 6.3%  
Gross profit margin %22.227.4 81.1%  
Effective tax rate %20.9-1.2 -1,713.4%   
Net profit margin %14.96.2 237.7%  
BALANCE SHEET DATA
Current assets Rs m19,5771,005,950 1.9%   
Current liabilities Rs m14,896877,274 1.7%   
Net working cap to sales %11.98.6 137.7%  
Current ratio x1.31.1 114.6%  
Inventory Days Days9091 98.8%  
Debtors Days Days4596 47.3%  
Net fixed assets Rs m27,097486,478 5.6%   
Share capital Rs m3773,666 10.3%   
"Free" reserves Rs m26,8110-   
Net worth Rs m27,1881,654,466 1.6%   
Long term debt Rs m4,993761,575 0.7%   
Total assets Rs m47,7783,403,808 1.4%  
Interest coverage x41.79.8 424.4%   
Debt to equity ratio x0.20.5 39.9%  
Sales to assets ratio x0.80.4 188.2%   
Return on assets %12.63.6 351.1%  
Return on equity %21.55.6 382.2%  
Return on capital %23.64.9 478.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m13,3880-   
CASH FLOW
From Operations Rs m8,120237,337 3.4%  
From Investments Rs m-7,556-84,098 9.0%  
From Financial Activity Rs m590-284,702 -0.2%  
Net Cashflow Rs m1,153-131,463 -0.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 73.32 Rs / USD

Compare ALEMBIC PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ALEMBIC PHARMA With: NEULAND LABS  GSK PHARMA  DISHMAN PHARMA  ABBOTT INDIA  STRIDES PHARMA SCIENCE  



Today's Market

5 Reasons Why Sensex Zoomed 613 Points Today(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note.

Related Views On News

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

Gland Pharma Q4 results: Net profit rises 34%; Share Price Hits New 52-Week High (Views On News)

May 18, 2021

The new vaccine business is expected to accelerate the company's long-term strategy of entering into the biosimilar space.

Cipla's Q4 Update: Net Profit Surges 68%; Company to Pay Rs 5 Dividend (Views On News)

May 17, 2021

Here's a rundown on the latest quarterly results of Cipla.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Revealing at 5pm Today: The Great Indian Wealth Project
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ALEMBIC PHARMA SHARE PRICE


May 18, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS